+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Heparin"

From
Antithrombotic Drugs Market - Global Strategic Business Report - Product Thumbnail Image

Antithrombotic Drugs Market - Global Strategic Business Report

  • Report
  • January 2026
  • 282 Pages
  • Global
From
Anticoagulant Reversal Drugs - Global Strategic Business Report - Product Thumbnail Image

Anticoagulant Reversal Drugs - Global Strategic Business Report

  • Report
  • January 2026
  • 140 Pages
  • Global
From
Fondaparinux - Global Strategic Business Report - Product Thumbnail Image

Fondaparinux - Global Strategic Business Report

  • Report
  • January 2026
  • 180 Pages
  • Global
From
Acute Coronary Syndrome - Global Strategic Business Report - Product Thumbnail Image

Acute Coronary Syndrome - Global Strategic Business Report

  • Report
  • January 2026
  • 158 Pages
  • Global
From
Anticoagulants - Global Strategic Business Report - Product Thumbnail Image

Anticoagulants - Global Strategic Business Report

  • Report
  • January 2026
  • 196 Pages
  • Global
From
From
Direct Oral Anticoagulants (DOACs) Device Market Report 2025 - Product Thumbnail Image

Direct Oral Anticoagulants (DOACs) Device Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Peptide and Anticoagulant Drugs Market Report 2025 - Product Thumbnail Image

Peptide and Anticoagulant Drugs Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Anticoagulant Reversal Drugs Market Report 2025 - Product Thumbnail Image

Anticoagulant Reversal Drugs Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Artery Stenosis Drug Market Report 2025 - Product Thumbnail Image

Artery Stenosis Drug Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Acute Ischemic Stroke Therapeutics Market Report 2025 - Product Thumbnail Image

Acute Ischemic Stroke Therapeutics Market Report 2025

  • Report
  • April 2025
  • 200 Pages
  • Global
From
From
From
From
Heparin-Induced Thrombocytopenia (HIT) - Pipeline Insight, 2025 - Product Thumbnail Image

Heparin-Induced Thrombocytopenia (HIT) - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
From
Thrombocytopenia - Pipeline Insight, 2025 - Product Thumbnail Image

Thrombocytopenia - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
P Selectin Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

P Selectin Inhibitors - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
Loading Indicator

Heparin is a type of anticoagulant drug used in the treatment of cardiovascular diseases. It is a naturally occurring anticoagulant, derived from the mucous membranes of animals, and is used to prevent the formation of blood clots. It is commonly used in the treatment of deep vein thrombosis, pulmonary embolism, and atrial fibrillation. It is also used to prevent clotting during hemodialysis and to prevent clotting during surgery. Heparin is available in both injectable and oral forms, and is typically administered in a hospital setting. It is also available in a variety of formulations, including low molecular weight heparin, unfractionated heparin, and fondaparinux. The cost of heparin varies depending on the formulation and the dosage. Heparin is a widely used anticoagulant in the cardiovascular drugs market. It is used in a variety of cardiovascular conditions, and is an important part of the treatment of many cardiovascular diseases. Some companies in the heparin market include Sanofi, Pfizer, Bristol-Myers Squibb, and GlaxoSmithKline. Show Less Read more